SCHEMBL5354628

SCHEMBL5354628

COC1(c2ccc(C=CC(=O)O)cc2)CCCCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.51
ATM Q13315 1/20 0.51
ALDH1A1 P00352 3/20 0.45
HCAR2 Q8TDS4 2/20 0.45
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA3 P07451 2/20 0.45
PKM P14618 2/20 0.45
CA4 P22748 2/20 0.45
CA6 P23280 2/20 0.45
CA5A P35218 2/20 0.45
CA7 P43166 2/20 0.45
CA9 Q16790 2/20 0.45
CA14 Q9ULX7 2/20 0.45
CA5B Q9Y2D0 2/20 0.45
ESR1 P03372 2/20 0.45
ESR2 Q92731 2/20 0.45
AKR1B10 O60218 1/20 0.45
TYR P14679 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3576599 0.73 ALDH1A1 (0.44) ALDH1A1TYRKDM4ESMN1; SMN2HSD17B10
SCHEMBL16024156 0.71 OPRM1 (0.54) KDM4EHSD17B10
SCHEMBL1040539 0.71 OPRM1 (0.54) KDM4EHSD17B10
SCHEMBL1040389 0.71 OPRM1 (0.54) KDM4EHSD17B10
SCHEMBL8318761 0.71 HCAR2 (0.53) THRBATMALDH1A1HCAR2CA12
SCHEMBL713717 0.71 HCAR2 (0.81) THRBATMALDH1A1HCAR2CA12
SCHEMBL68395 0.71 HCAR2 (0.81) THRBATMALDH1A1HCAR2CA12
SCHEMBL14081549 0.71 HCAR2 (0.81) THRBATMALDH1A1HCAR2CA12
SCHEMBL12894551 0.71 KDM4E (0.51) THRBATMALDH1A1HCAR2CA12
Cinnamic Acid SCHEMBL28731806 0.69 HCAR2 (0.86) THRBATMALDH1A1HCAR2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4683608-A1 PROCESS FOR THE PREPARATION OF A POLAR LIPID-ENRICHED ALGAL EXTRACT Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) 2026-01-28 EP disclosed
EP-4683609-A1 HIMANTHALIA ELONGATA EXTRACT, COSMETIC COMPOSITION COMPRISING SAME, AND USES THEREOF Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) 2026-01-28 EP disclosed
US-20250319013-A1 THICKENING COMPOSITION FOR THICKENING POLAR OR NON-POLAR OILS SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2025-10-16 US disclosed
US-20250302706-A1 METHOD FOR IMPROVING THE SENSORIAL PROPERTIES OF OIL-IN-WATER EMULSIONS SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2025-10-02 US disclosed
US-12364653-B2 Method for improving the sensorial properties of oil-in-water emulsions SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2025-07-22 US disclosed
US-20250032395-A1 COPOLYMER THICKENING COMPOSITION COMPRISING AT LEAST ONE OIL AND AT LEAST ONE POLY(ITACONATE) FOR THICKENING POLAR OR APOLAR OILS SOCIETE D’EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2025-01-30 US disclosed
CN-114206308-B Anhydrous composition for topical use in the form of a dispersed phase based on at least one short glycol in a continuous fatty phase 化工产品开发公司SEPPIC 2024-11-19 CN disclosed
WO-2024194369-A1 PROCESS FOR THE PREPARATION OF A POLAR LIPID-ENRICHED ALGAL EXTRACT SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2024-09-26 WO disclosed
WO-2024194370-A1 HIMANTHALIA ELONGATA EXTRACT, COSMETIC COMPOSITION COMPRISING SAME, AND USES THEREOF SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2024-09-26 WO disclosed
EP-4349418-A2 TOPICALLY ADMINISTRABLE HELICHRYSUM STOECHAS PLANT DEDIFFERENTIATED CELL LYSATE (LY) FOR REMOVING OR REDUCING SKIN INFLAMMATION Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) 2024-04-10 EP disclosed
EP-3554462-A1 METHOD FOR IMPROVING THE SENSORIAL PROPERTIES OF OIL-IN-WATER EMULSIONS Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) 2019-10-23 EP disclosed
WO-2019197777-A1 NOVEL COMPOSITION BASED ON POLYCAFFEOYLQUINIC ACIDS, THE USE THEREOF IN COSMETICS AND COSMETIC COMPOSITIONS COMPRISING SAME SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2019-10-17 WO disclosed
WO-2019197774-A1 USE OF SORBITYL POLYRHAMNOSIDES AS HUMAN SKIN LIGHTENING AGENTS SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2019-10-17 WO disclosed
US-10052275-B2 Surfactant-free self-reversible reverse latex, and use of same as a thickening agent in a cosmetic composition SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2018-08-21 US disclosed
US-20170312205-A1 USE OF ESTERS OF N-ACYLATED DERIVATIVES OF AMINO ACIDS AND POLYOLS AS AN ANTI-AGEING AGENT FOR HUMAN SKIN SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2017-11-02 US disclosed
US-20170304177-A1 USE OF ISOSORBIDE ESTER AND N-ACYLATED AMINO ACID DERIVATIVES AS ANTI-AGEING AGENT FOR THE HUMAN SKIN SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2017-10-26 US disclosed
US-20160015609-A1 NOVEL WATER-IN-OIL EMULSIONS WITH A HIGH CONTENT OF AQUEOUS PHASE AND OF LIQUID CONSISTENCY, WHICH ARE STABLE ON STORAGE SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2016-01-21 US disclosed
US-20150098915-A1 NOVEL SURFACTANT-FREE SELF-REVERSIBLE REVERSE LATEX, AND USE OF SAME AS A THICKENING AGENT IN A COSMETIC COMPOSITION SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2015-04-09 US disclosed
US-7226580-B2 Topical compositions with an oily outer phase and process for their preparation SEPPIC (FR) 2007-06-05 US disclosed
US-20040071642-A1 Novel topical compositions with an oily outer phase and process for their preparation SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES-SEPPIC 2004-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040071642-A1 Novel topical compositions with an oily outer phase and process for their preparation CUTA, TYR, ERCC5 THRB 4802/4885ATM 3254/4885ALDH1A1 273/4885
US-20160015609-A1 NOVEL WATER-IN-OIL EMULSIONS WITH A HIGH CONTENT OF AQUEOUS PHASE AND OF LIQUID CONSISTENCY, WHICH ARE STABLE ON STORAGE DEGS1, PHOSPHO1, DAGLA THRB 4669/4885ATM 340/4885ALDH1A1 280/4885
US-20150098915-A1 NOVEL SURFACTANT-FREE SELF-REVERSIBLE REVERSE LATEX, AND USE OF SAME AS A THICKENING AGENT IN A COSMETIC COMPOSITION DEGS1, SRM, SMURF1 THRB 4325/4885ATM 3280/4885ALDH1A1 1039/4885
US-20170304177-A1 USE OF ISOSORBIDE ESTER AND N-ACYLATED AMINO ACID DERIVATIVES AS ANTI-AGEING AGENT FOR THE HUMAN SKIN ARG2, ARGLU1, ASS1 THRB 2266/4885ATM 1195/4885ALDH1A1 714/4885
US-10052275-B2 Surfactant-free self-reversible reverse latex, and use of same as a thickening agent in a cosmetic composition DEGS1, SMURF1, SRM THRB 4136/4885ATM 2857/4885ALDH1A1 914/4885
US-20250302706-A1 METHOD FOR IMPROVING THE SENSORIAL PROPERTIES OF OIL-IN-WATER EMULSIONS LIPA, OR51E2, TAS2R31 THRB 3639/4885ATM 761/4885ALDH1A1 2589/4885
US-20170312205-A1 USE OF ESTERS OF N-ACYLATED DERIVATIVES OF AMINO ACIDS AND POLYOLS AS AN ANTI-AGEING AGENT FOR HUMAN SKIN LPO, ARG2, CUTA THRB 2232/4885ATM 1780/4885ALDH1A1 2530/4885
US-20250319013-A1 THICKENING COMPOSITION FOR THICKENING POLAR OR NON-POLAR OILS PHOSPHO1, ELOVL5, PARG THRB 4046/4885ATM 2476/4885ALDH1A1 4873/4885
US-20250032395-A1 COPOLYMER THICKENING COMPOSITION COMPRISING AT LEAST ONE OIL AND AT LEAST ONE POLY(ITACONATE) FOR THICKENING POLAR OR APOLAR OILS SOAT1, NOTUM, CPT1A THRB 2694/4885ATM 2864/4885ALDH1A1 3271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.